Antimicrobial treatment of laryngeal leukoplakia
Phase 4
Not yet recruiting
- Conditions
- laryngeal leukoplakia
- Registration Number
- 2024-518793-14-00
- Lead Sponsor
- HUS-Yhtymae
- Brief Summary
Antimicrobial treatment of laryngeal leukoplakia
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised, recruitment pending
- Sex
- Not specified
- Target Recruitment
- 90
Inclusion Criteria
laryngeal leukoplakia
Exclusion Criteria
a known allergy to the investigational medicinal product, pregnancy, hepatic insufficiency, drug interaction, warfarin
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method disappearance of leukoplakia disappearance of leukoplakia
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
HUS-Yhtymae
🇫🇮Helsinki, Finland
HUS-Yhtymae🇫🇮Helsinki, FinlandPetra PietarinenSite contact+358504271588petra.pietarinen@hus.fi